DEAD

Serial Number

87072521

Owner

Aegerion Pharmaceuticals, Inc.

Attorney

Todd Armstrong

First Use Date

Nov 29, 2016

Filing Date

Jun 15, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NOVELION THERAPEUTICS Trademark

Serial Number: 87072521 • Registration: 5381517

NOVELION THERAPEUTICS is a trademark filed by Aegerion Pharmaceuticals, Inc. on June 15, 2016. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Aegerion Pharmaceuticals, Inc. (33 trademarks)

Centerpointe IV, 1140 Route 22 East
Bridgewater, NJ 08807

Entity Type: 03

NOVELION THERAPEUTICS INC. (7 trademarks)

1800 - 510 WEST GEORGIA STREET
VANCOUVER BC V6B 0M , CA

Entity Type: 03

Legal Representation

Attorney of Record

Todd Armstrong

20 trademarks filed View all →

Trademark Details

Filing Date

June 15, 2016

Registration Date

January 16, 2018

First Use Anywhere

November 29, 2016

First Use in Commerce

November 29, 2016

Published for Opposition

March 21, 2017

Cancellation Date

July 26, 2024

Goods & Services

Pharmaceutical research and development

Filing History

CANCELLED SEC. 8 (6-YR)

Jul 26, 2024 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jan 16, 2023 REM1

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Sep 25, 2019 ASGN

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 18, 2018 ASCK

REGISTERED-PRINCIPAL REGISTER

Jan 16, 2018 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 12, 2017 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 9, 2017 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 22, 2017 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Nov 21, 2017 SUPC

SOU EXTENSION 1 GRANTED

Nov 21, 2017 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 20, 2017 AITU

USE AMENDMENT FILED

Nov 14, 2017 IUAF

SOU EXTENSION 1 FILED

Nov 14, 2017 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 14, 2017 EEXT

TEAS STATEMENT OF USE RECEIVED

Nov 14, 2017 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 16, 2017 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 21, 2017 NPUB

PUBLISHED FOR OPPOSITION

Mar 21, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 1, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 8, 2017 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 2, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 1, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 1, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 6, 2016 GNRN

NON-FINAL ACTION E-MAILED

Sep 6, 2016 GNRT

NON-FINAL ACTION WRITTEN

Sep 6, 2016 CNRT

ASSIGNED TO EXAMINER

Sep 4, 2016 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jun 22, 2016 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 21, 2016 NWOS

NEW APPLICATION ENTERED

Jun 18, 2016 NWAP

Related Trademarks

More from this Owner

NOVELION THERAPEUTICS

More in Same Class